IGMS (IGM Biosciences Inc.) Volume dana dhuwit perusahaan

Logo grafis igmbio.com (IGMS)

Laboratory robotization for IgM antibody synthesis ensures high process precision for IGM Biosciences, Inc. (IGMS). The company's cash position confirms this status, with the metric standing at 0.06. The asset's resilience is based on the autonomy of the medical cycle, although geopolitical tensions may hinder international testing and chemical supplies.

IGMS - Aset likuid perusahaan igmbio.com ing rentang 04.07.2022 - 24.08.2025

Rincian analitis lan laporan data perusahaan IGM Biosciences, Inc. (IGMS)

Analisis fundamental perusahaan:igmbio.com
Produk mawa merek IGM Bio

This indicator reflects the current volume of liquid assets, determining the issuer's ability to cover operating expenses and liabilities. For IGM Biosciences, Inc. (IGMS), this resource is critical as it funds costly oncology R&D processes regardless of market cycles. By analyzing the amount of cash reserves, an investor assesses the "margin of safety" before clinical trial results are obtained. A stable cash balance minimizes the risks of underfunding development. Long-term liquidity growth confirms the sustainability of the business model.

Pesaing utama

Volume dana dhuwit perusahaan ARGX|BioNTech - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan ABVX (abivax.com)|Sisa dhuwit perusahaan ADMA|Protagonist Therapeutics, Inc. - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Immunovant, Inc.|KNSA: Volume dana dhuwit perusahaan|GRFS - Aset likuid perusahaan|ADPT (Adaptive Biotechnologies Inc.) - Volume dana dhuwit perusahaan|CLDX: Sisa dhuwit perusahaan|Dana dhuwit perusahaan Aurinia Pharmaceuticals Inc. (AUPH)|Dana dhuwit perusahaan BCRX (BioCryst Pharmaceuticals Inc)|Volume dana dhuwit perusahaan VERA (Vera Corp)|Gunggung dana dhuwit perusahaan DNTH (Dianthus Therapeutics)|PHVS - Dana dhuwit perusahaan|ABCL: Dana dhuwit perusahaan|TRML: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Precigen, Inc.|Dhuwit awis perusahaan PHAR|Nektar Therapeutics - Total volume dana dhuwit perusahaan|Dana dhuwit perusahaan Upstream Bio Corp (UPB)|Dhuwit awis perusahaan Zenas Biopharma ZBIO|Dana dhuwit perusahaan Immunome Bio IMNM|GOSS: Dhuwit awis lan setara dhuwit awis perusahaan|kalvista.com - Volume dana dhuwit perusahaan|SEPN (septerna.com) - Dhuwit awis lan setara dhuwit awis perusahaan|PVLA (Pieris Pharmaceuticals) - Dhuwit awis perusahaan|Savara - Sisa dhuwit perusahaan|RIGL (Rigel Corp) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan AnaptysBio Corp|Dana dhuwit perusahaan astriatx.com (ATXS)|Dhuwit awis perusahaan enGene ENGN|Dana dhuwit perusahaan RAPT Therapeutics, Inc. RAPT|JBIO - Dhuwit awis perusahaan|Aclaris Therapeutics Inc. - Volume dana dhuwit perusahaan|KYTX - Volume dana dhuwit perusahaan|TLSA (Tiziana Life Sciences PLC) - Dhuwit awis perusahaan|cabalettabio.com (CABA) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Ventyx Biosciences|THTX (Theratechnologies) - Gunggung dana dhuwit perusahaan|Dhuwit awis perusahaan AVTX (Avalo Therapeutics Inc.)|Dana dhuwit perusahaan ELDN (Eledon)|Volume dana dhuwit perusahaan AGEN (Agenus, Inc)|Aset likuid perusahaan climbbio.com (CLYM)|zurabio.com - Volume dana dhuwit perusahaan|ATYR - Volume dana dhuwit perusahaan|ADAG: Volume dana dhuwit perusahaan|Ikena Oncology, Inc. (IMA) - Volume dana dhuwit perusahaan|STTK (Shattuck Therapeutics) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan equilliumbio.com EQ|Volume dana dhuwit perusahaan CNTB|IMUX - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan Atara Biotherapeutics ATRA|Aset likuid perusahaan InflaRx N.V. (IFRX)|XFOR: Dhuwit awis perusahaan|adicetbio.com (ACET) - Dhuwit awis perusahaan|CELU: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan INmune Bio (INMB)|Dana dhuwit perusahaan Barinthus Bio|Dhuwit awis lan setara dhuwit awis perusahaan KZR (Kezar Life Sciences, Inc)|Dhuwit awis perusahaan SABS (SAB Biotherapeutics Inc)|Akari Therapeutics - Dhuwit awis lan setara dhuwit awis perusahaan|Enlivex Therapeutics Ltd - Dhuwit awis perusahaan|Sisa dhuwit perusahaan QTTB|GOVX - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Edesa|IBIO: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Carisma Therapeutics Inc (CARM)|Dana dhuwit perusahaan XTL Biopharmaceuticals, Ltd.|Dana dhuwit perusahaan BOLT|Dhuwit awis perusahaan HCWB (HCW Biologics, Inc.)|Gunggung dana dhuwit perusahaan APVO|AIM ImmunoTech - Dhuwit awis perusahaan|Sisa dhuwit perusahaan ADTX|GRI - Dana dhuwit perusahaan|XRTX (XORTX Therapeutics Inc) - Dhuwit awis lan setara dhuwit awis perusahaan|HIND: Volume dana dhuwit perusahaan|REVB (Revelation Bio) - Dana dhuwit perusahaan|Dana dhuwit perusahaan Indaptus|Scinai Immunotherapeutics (SCNI) - Aset likuid perusahaan|Volume dana dhuwit perusahaan CALI|Dhuwit awis perusahaan Affimed NV AFMD|Dana dhuwit perusahaan Allakos Inc ALLK|HOOK (HOOKIPA) - Total volume dana dhuwit perusahaan|iTeos Pharma - Volume dana dhuwit perusahaan|Aset likuid perusahaan oceanbiomedical.com OCEA|TC BioPharm (TCBP) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan THRD